Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
30.77
+1.52 (5.20%)
At close: Jun 26, 2026, 4:00 PM EDT
30.00
-0.77 (-2.50%)
After-hours: Jun 26, 2026, 6:54 PM EDT
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,371 employees as of December 31, 2025. The number of employees increased by 77 or 5.95% compared to the previous year.
Employees
1,371
Change (1Y)
77
Growth (1Y)
5.95%
Revenue / Employee
$488,694
Profits / Employee
-$444,201
Market Cap
3.02B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Alumis | 227 |
| uniQure | 221 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
RARE News
- 8 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Ultragenyx Pharmaceutical Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald - TheFly
- 6 weeks ago - Ultragenyx Pharmaceutical Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Ultragenyx Pharmaceutical Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Ultragenyx price target lowered to $33 from $34 at Evercore ISI - TheFly
- 7 weeks ago - Ultragenyx price target lowered to $26 from $27 at Wedbush - TheFly